NDC 0409-1555-64 - Hextend
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1555
- Requested NDC
- 0409-1555-64
- Package NDCs from labels
- 0409-1555-64, 0409-1555-54
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-05-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HEXTEND ® Rx only | Hospira, Inc. | 2026-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-02-15 | HEXTEND ® Rx only |
| 2023-02-15 | HEXTEND ® Rx only |
| 2023-01-30 | HEXTEND ® Rx only |
| 2023-01-30 | HEXTEND ® Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1555-54 | Hextend | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 25 | |
| 0409-1555-64 | Hextend | 500 mL in 1 BAG | INJECTION, SOLUTION | 500 | 25 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1555-54 | ML - Milliliter | 0409-1555 | 842fc9fb-3e91-4558-b09b-9523cd8ba413 | 1 | 2014-02-04 |
| 0409-1555-64 | ML - Milliliter | 0409-1555 | 0631648e-e1ec-446e-9113-577b350bc26e | 1 | 2015-08-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HETASTARCH | ACTIVE INGREDIENT | 875Y4127EA | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| HETASTARCH | ACTIVE MOIETY | 875Y4127EA | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| CALCIUM CHLORIDE | INACTIVE INGREDIENT | M4I0D6VV5M | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| MAGNESIUM CHLORIDE | INACTIVE INGREDIENT | 02F3473H9O | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| POTASSIUM CHLORIDE | INACTIVE INGREDIENT | 660YQ98I10 | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM LACTATE | INACTIVE INGREDIENT | TU7HW0W0QT | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Hospira, Inc. | 559a0a8c-a8fe-40a5-b196-21f9308780ab | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 30527e49-6648-44f3-97b2-9c51783ac003 | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals NY LLC | 590dd25c-c4cb-489a-a09b-eccbf1d37c1f | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55820ff9-7b4b-2bce-e063-6394a90a8b43 | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55806cb8-cf92-c4e5-e063-6394a90aaa2d | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 5581d8e5-4105-e9da-e063-6394a90a316e | 2026-06-30 | Warnings | 451W47IQ8X |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Nervionoix Pro Neuropathy Fast Acting Cream | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 23abdf62-03a8-4aaa-8e29-0e2585b5ade7 | 2026-06-24 | Warnings | 02F3473H9O |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Potassium Chloride | POTASSIUM CHLORIDE | St. Mary's Medical Park Pharmacy | 549c9d28-bf8b-2dc2-e063-6294a90abe7b | 2026-06-19 | Warnings, Adverse reactions | 660YQ98I10 |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.